HRA Pharma Breaks Into US Consumer Health Market With Mederma Acquisition

EllaOne and Compeed manufacturer HRA Pharma is set to establish a notable presence in the US consumer health market by acquiring the Mederma dermatology range from Germany's Merz.

Handshake
• Source: Shutterstock

France’s HRA Pharma SA is poised to establish a solid footing in the US consumer health market by acquiring from Germany’s Merz GmbH & Co. KGaA the popular Mederma OTC dermatology brand.

Through the deal - slated to close within the second quarter - HRA will gain the global rights to the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business